FDA-approved heterocyclic molecules for cancer treatment: Synthesis, dosage, mechanism of action and their adverse effect

Autor: Hossain, Mossaraf, Habib, Imran, Singha, Koustav, Kumar, Anoop

Publikováno v: In Heliyon 15 January 2024 10(1)

Transition metal-free C–H activation of heteroarenes: an overview (2018–2022).

Autor: Habib, Imran¹ (AUTHOR), Singha, Koustav¹ (AUTHOR), Hossain, Mossaraf¹ (AUTHOR)

Publikováno v: Synthetic Communications. 2023, Vol. 53 Issue 1, p1-22. 22p. 3 Diagrams, 4 Charts, 6 Graphs.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

FDA-approved heterocyclic molecules for cancer treatment: Synthesis, dosage, mechanism of action and their adverse effect.

Autor: Hossain M; Synthetic Organic Research Laboratory, UGC-HRDC (Chemistry), University of North Bengal, Darjeeling, 734013, India., Habib I; Synthetic Organic Research Laboratory, UGC-HRDC (Chemistry), University of North Bengal, Darjeeling, 734013, India., Singha K; Synthetic Organic Research Laboratory, UGC-HRDC (Chemistry), University of North Bengal, Darjeeling, 734013, India., Kumar A; Department of Biotechnology, University of North Bengal, Darjeeling, 734013, India.

Publikováno v: Heliyon [Heliyon] 2023 Dec 05; Vol. 10 (1), pp. e23172. Date of Electronic Publication: 2023 Dec 05 (Print Publication: 2024).